CPI - Adjustment Factors (actual) - 2011
Preliminary Price-Adjustment Factors (Based on Forecast Inflation Rates)
Table 1 reproduces preliminary price-adjustment factors for 2011 published in the April 2010 NEWSletter. These factors were based on forecasted annual CPI-inflation rates of 1.7% and 2.2% for 2010 and 2011, respectively.
Table 1 Preliminary 2011 Price-Adjustment Factors for Patented Drug Products (Based on Forecast CPI-Inflation Rates for 2010 and 2011)
Benchmark Year |
(1) 2008 |
(2) 2009 |
(3) 2010 |
Price-Adjustment Factor |
1.043 |
1.039 |
1.022 |
These figures imply: (1) a maximum allowable cumulative price increase between 2008 and 2011 of 4.3% for patented drug products with Canadian sales in 2008 (that is, products whose “benchmark year” is 2008); (2) a maximum allowable cumulative price increase between 2009 and 2011 of 3.9% for products whose first Canadian sales occurred in 2009; and (3) a maximum allowable cumulative price increase between 2010 and 2011 of 2.2% for products whose first Canadian sales occurred in 2010.
In addition, the forecast inflation rate of 2.2% for 2011 implies a year-over-year price increase cap (applicable to all drug products, regardless of benchmark year) of 3.3% (= 1.5 x 2.2%) for 2011.
Final Price-Adjustment Factors (Based on Actual Inflation Rates)
The actual rate of CPI inflation for 2010 of 1.8% was published in the January 2011 NEWSletter. The actual rate of CPI inflation for 2011 is now available and was 2.9%. These rates (along with the actual 2009 CPI-inflation rate of 0.3%) yield the following final price-adjustment factors.
Table 2 Final 2011 Price-Adjustment Factors for Patented Drug Products (Based on Actual CPI-Inflation Rates for 2010 and 2011)
Benchmark Year |
(1) 2008 |
(2) 2009 |
(3) 2010 |
Price-Adjustment Factor |
1.051 |
1.047 |
1.029 |
The final year-over-year price increase cap for 2011 is 4.4 % (= 1.5 x 2.9%).